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Abstract Recent weeks have seen an increased focus
on the ethical response to the COVID-19 pandemic.
Ethics guidance has proliferated across Britain, with
ethicists and those with a keen interest in ethics in
their professions working to produce advice and sup-
port for the National Health Service. The guiding
principles of the pandemic have emerged, in one
form or another, to favour fairness, especially with
regard to allocating resources and prioritizing care.
However, fairness is not equivalent to equity when it
comes to healthcare, and the focus on fairness means
that existing guidance inadvertently discriminates
against people from ethnic minority backgrounds.
Drawing on early criticisms of existing clinical guid-
ance (for example, the frailty decision tool) and eth-
ical guidance in Britain, this essay will discuss the
importance of including sociology, specifically the
relationship between ethnicity and health, in any
ethical and clinical guidance for care during the pan-
demic in the United Kingdom. To do otherwise, I will
argue, would be actively choosing to allow a propor-
tion of the British population to die for no other
reason than their ethnic background. Finally, I will
end by arguing why sociology must be a key compo-
nent in any guidance, outlining how sociology was
incorporated into the cross-college guidance pro-
duced by the Royal College of Physicians.
Keywords COVID-19 . Pandemic ethics . Health
inequalities . Ethnic minorities . Social sciences and
ethics . Ethical guidelines
Introduction
Recent weeks have seen an increased focus on the
ethical response to the COVID-19 pandemic. Notably
absent in Britain, despite calls from several sources
(Paton 2020; Fritz, Houlton, and Fuld 2020; Archard
andWhittal 2020; Royal College of Physicians 2020), is
obligatory national ethics guidance on care during the
COVID-19 pandemic.1 In its absence, ethics guidance
has proliferated, with ethicists and those with a keen
interest in ethics in their professions working to produce
advice and support for the National Health Service
(NHS). The Royal College of Physicians has issued
cross-college guidance for all medical frontline staff
(2020), and the British Medical Association has issued
guidance for doctors (2020). Beyond the professional
bodies, the Nuffield Council of Bioethics has issued
advice on research and global and government respon-
sibilities during the pandemic.2 Internationally, the Has-
tings Center has issued guidance for the United States,
the worst hit country in the pandemic. Despite ethics
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1 The Moral and Ethical Advisory Group for the United Kingdom
government is using an ethical framework developed in 2007 and
updated in 2017. However, this is not a national framework, and it is
not obligatory for institutions to adopt it.
2 See https://www.nuffieldbioethics.org/topics/health-and-
society/covid-19 for all up-to-date guidance.
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scholars focusing on slightly different professions and
using different theoretical approaches to crafting their
guidance, globally there is a consensus that ethics guid-
ance is needed and consensus on what that guidance
should look like. The guiding principles of the pandemic
have emerged, in one form or another, to favour ac-
countability, transparency, the duty of care, equity, and
respect for patients (Royal College of Physicians 2020).
Uniting these principles is the importance of “fair-
ness” in pandemic planning, guidance, and policy. Fair-
ness, whether through a utilitarian approach to assigning
limited resources (as seen in Italy) or a reverse triage
approach (advocated by the Royal College of Physi-
cians), has emerged as the paramount value of
COVID-19 good practice. However, this reliance on
fairness is misguided, as the pandemic is categorically
unfair. This is because the value of “fairness” when
operationalized into guidance, and resulting policy, fails
to account for the many inherent ways that our society is
not fair when it comes to health. Despite government
pronouncements that the pandemic does not discrimi-
nate, COVID-19 has in fact disproportionately discrim-
inated against certain groups of British society, hitting
people from ethnic minority backgrounds and those
living in areas of high deprivation the hardest (Cook
et al. 2020; Paton et al. 2020). Fairness does not neces-
sarily mean “equity”when it comes to health. In the rush
to create “fair” guidance, the social sciences have been
largely forgotten. This has resulted in inadvertent dis-
criminatory guidance, as COVID-19 lays bare what
happens when policy and guidance ignore the social
determinants of health and illness and the resulting
health inequalities they create.
Using evidence on the impact of COVID-19 on
people from ethnic minority backgrounds3 and drawing
on criticisms of existing clinical guidance using socio-
logical theory and evidence, this essay discusses the
importance of including sociology in ethical, but also
clinical, guidance for care during the pandemic in the
United Kingdom. To do otherwise would be actively
choosing to allow a proportion of the British population
to die for no other reason than their ethnic background.
Finally, I show how sociology, as one of the fields that
“does” bioethics, is a necessary component for ethics
guidance, outlining how sociology has been incorporat-
ed into the cross-college guidance produced by the
Royal College of Physicians.
The Impact of COVID-19 on People From Ethnic
Minority Backgrounds
Currently 35 per cent of patients critically ill with con-
firmed COVID-19 are from the Black, Asian, and mi-
nority ethnic (BAME)4 population in Britain (Intensive
Care National Audit and Research Centre [ICNARC]
2020), and an equally disproportionate number of the
BAME population have died from the virus (Barr et al.
2020). This is excessively high given that this same
group comprises only 14 per cent of the U.K. population
(ICNARC 2020). However, these numbers are not just
about risk factors related to ethnicity. They raise deeper
questions about how ethical and clinical guidance has
influenced the pandemic measures taken, measures
which have exacerbated the relationship between eth-
nicity, living conditions, occupation, underlying health
conditions, and deprivation. In every instance, the guid-
ance and measures unfairly disadvantage the BAME
population.
Take for example the guidelines for social distancing
and living conditions. While 79.1 per cent of the white
population lives in densely populated urban areas,
where it is difficult to practice social distancing, 98.1
per cent of Black and 97.4 per cent of Asian minority
groups live in those same environments, making them
more susceptible to infection than the white population
(ONS 2019). Additionally, the rate of overcrowding for
all BAME groups (range 3 per cent to 30 per cent) is
higher than in white British households (2 per cent)
(Ministry of Housing 2015, 2016, 2017).
People from BAME backgrounds are also over-
represented in higher-risk, essential occupations. Doc-
tors from BAME backgrounds represent around 40 per
cent of the existing medical workforce in the United
Kingdom (Nagpual 2020), with an estimated 64 per cent
of COVID-19 related healthcare worker deaths being
people from BAME backgrounds (Cook et al. 2020).
Beyond healthcare, BAME workers are over-
represented in sectors that have continued to work
3 I could equally have chosen to focus on outcomes of patients from
areas of deprivation, but for the sake of brevity, I will focus on only one
high-risk group in this article. There is, of course, crossover between
these two groups, with many people from ethnic minority backgrounds
also living in areas of deprivation, leaving them even more at risk then
the equivalent white population.
4 In this article I will use “people from ethnic minority backgrounds”
and BAME interchangeably.
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face-to-face, like transport, distribution, and retail sec-
tors (McGregor-Smith 2017).
Besides being an inconvenient truth for the British
health and social care system that our current govern-
ment wishes to ignore, consistent dismissal of the social
determinants of health and illness has led to an igno-
rance of its important role when developing guidance
for healthcare. Historically there has been very little
policy or public health work done on mitigating ethnic
health inequalities, as they have often been wrongly
attributed to differences between cultures (Chouhan
and Nazroo 2020). However, the need for new guidance
in the pandemic provides an opportunity to reorient
policy and public health measures such that they con-
sider “the social character of ethnicity, and the socially
and economically determined nature of health”
(Chouhan and Nazroo 2020, 73). Instead, the focus
has been generalizability in an attempt to be “fair.”
Is Existing Guidance Really Fair?
The focus on generalizability glosses over important
ways that health is influenced by ethnicity. Ethics guid-
ance that focuses on generalizability ignores the social
scientific evidence that not everyone has an equal
chance at good health or even equal access to healthcare
services. Advising that it is okay to choose certain
patients over others for escalation of care in a pandemic5
has trickled down to clinical guidance, where it un-
knowingly, but actively, discriminates against people
from ethnic minority backgrounds. If you are allowed
to choose between patients, then criteria are necessary to
make that choice. Much of the existing guidance argues
that, for fairness, the criteria should as much as possible
be about objective, clinical outcomes; however, social
outcomes have been discussed too (British Medical
Association 2020).
However, existing clinical guidance designed to pri-
oritize patients fairly for escalation of care discriminates
against people from ethnic minority backgrounds by
using co-morbidities more common in the BAME pop-
ulation to exclude patients. For example, heart disease is
one of the most common underlying conditions in dead-
ly cases of COVID-19 (Office for National Statistics
2020). Heart disease has a higher prevalence in three
ethnic minority groups well represented in the British
population—South Asian, African, and African Carib-
bean (British Heart Foundation 2020)—thus dispropor-
tionately affecting the clinical outcomes of these groups
due to ethnicity. Similarly, asthma has a higher preva-
lence in BAME groups (Netuveli, Hurwitz, and Sheikh
2005; Sheikh et al. 2016), in large part due to their over-
representation in more deprived areas with poor air
quality (Guarnieri and Balmes 2014; Cai et al. 2017).
A concerning fact when asthma is one of the underlying
conditions for which individuals must shield themselves
for twelve weeks to avoid possible hospitalization
should they fall ill (Public Health England 2020).
Failure to work with social scientists and data
from the social sciences only serves to worsen the
already existing systematic disadvantage that
BAME patients already find themselves in with
regards to health and well-being (Postnote 2007;
Daugherty Biddeson et al. 2019; BMJ 2020;
Chouhan and Nazroo 2020). Previous work on
pandemic clinical guidance has shown that when
emphasis is placed on long-term survival and co-
morbidity to determine priority of care, existing
clinical guidance (such as the frailty tool) dispro-
portionately disadvantages the BAME population
(Daugherty Biddeson et al. 2019). For example,
people of South Asian background are at a higher
risk of cardiovascular problems, such as angina
(British Heart Foundation 2020). The documents
that the National Institute of Health and Care
Excellence (N.I.C.E.) provides doctors to support
decision-making during the pandemic focus on
mortality in cardiovascular co-morbidities, explicit-
ly naming angina as a condition that could be used
to determine whether escalation to critical care is
appropriate for COVID-19 patients (N.I.C.E.
2020). The focus on underlying heart disease to
exclude patients from critical care, while clinically
relevant, is just one example of how BAME
groups will not receive the same care as white
British patients if existing guidance fails to take
account of the relationship between ethnicity and
health.
Additionally, generalizability, in the form of univer-
sality, rarely works well when bioethics is put into
practice (Paton 2017). Previous work using sociological
research has shown that ethical theory developed with-
out empirical data on the context within which it will be
used and understood is considered unhelpful by patients
5 Such has been done in Italy, a move supported by the BMA in their
ethics guidance.
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and staff in supporting ethical medical practice (Padela
et al. 2015; Paton 2017; Paton 2019; Paton and Kotzee
2019). This is not just another shot fired in the empirical
versus theoretical debate that rages in bioethics litera-
ture6 but an important point about ensuring relevancy in
the advice that bioethics is supposed to provide. In a
pandemic, but in other areas of medicine too, this advice
has life or death consequences. Put simply, when the
social sciences are ignored in favour of theory devel-
oped by white philosophers several hundred years dead,
the wrong people die, in their thousands.
As another example, consider how generalizability in
ethical guidelines for medical frontline staff actively
discriminates against the BAME population. Current
ethics guidance focuses on protecting staff with ac-
knowledged clinical vulnerabilities, advocating that
these staff be shielded or redeployed to protect them-
selves from infection. Despite the now established rela-
tionship between ethnicity and poor outcomes, there is
currently no specific ethics guidance regarding BAME
frontline staff who are also potentially vulnerable be-
cause of this relationship. As a result, as a group they are
not being offered the same options to protect and shield
themselves. Given that they make up almost half of our
medical workforce, guidance on how best to protect our
BAME medical frontline staff during the pandemic is
urgently needed but has yet to be developed by the
government. Ethics guidance that promotes a duty of
care towards clinician well-being, must explicitly advo-
cate that BAME staff be additionally shielded through
redeployment or additional personal protective equip-
ment to best protect them from the increased risk of
infection and death.
Building Ethical and Clinical Guidance on a Social
Sciences Foundation
Oddly, making guidelines truly fair is relatively easy,
though governments have been resistant to these chang-
es. For example, clinical guidance could consider re-
search following the H1N1 pandemic in the United
States (Daugherty Biddeson et al. 2019),7 which
recommends that decisions about long-term survival
based on co-morbidities be limited to those patients
whose underlying conditions mean they are expected
to die in under twelve months. Those with co-
morbidities that will live beyond twelve months should
not have their co-morbidities used to determine eligibil-
ity for treatment, thus helping to avoid discrimination of
those groups more likely to have been living with these
conditions (often long-term) due to ethnic and/or socio-
economic background.
Equally, for ethical guidance we can look to the
existing Royal College of Physicians ethical guidance
for frontline staff. The Royal College of Physicians took
as their starting point an empirical bioethics approach
that prioritized sociological work in ethics (Haimes
2002; Scully 2010; Paton 2017, 2018a). Using social
science analyses of ethical frameworks and clinical
guidance used during the SARS pandemic (Thompson
et al. 2006) and the H1N1 pandemic (Daugherty
Biddeson et al. 2019), the Royal College of Physicians
developed an ethical framework for decision-making
based on social scientific work on ethics and pandemics.
Reference to this work allowed them to develop with
confidence their arguments for accountability, inclusiv-
ity, transparency, reasonableness, and responsiveness as
guiding principles of the pandemic (Royal College of
Physicians 2020), principles known to have been useful
during the SARS pandemic of 2003 (Thompson et al.
2006).
Social scientific work on people’s perceptions of a
doctor’s duty of care extending to the protection of
doctors themselves shaped their advice to frontline staff
on working with insufficient personal protective equip-
ment, shielding, and redeployment (Bensimon et al.
2012). Empirical work on the role of cultural perspec-
tives and contexts in pandemic responses (Lor et al.
2016) were used to develop advice for doctors around
the importance of considering a patient’s context when
making decisions about care priorities. As the Royal
College of Physicians guidance shows, it is possible to
do things differently and ultimately equitably when
developing ethical guidance to best reflect the context
within which that guidance will be used.
Conclusion
Existing ethical and clinical guidelines for care during
the pandemic are largely unfair. They actively
6 One I will not engage in here, as empirical bioethics and the role of
sociology in bioethics has been firmly established in the field by
Haimes (2002), Scully (2010), and most recently Paton (2017,
2018a, 2018b, 2019).
7 Where pandemics have disproportionately affected minority ethnic
groups.
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discriminate against people from ethnic minority back-
grounds. When the context within which guidelines will
be used are not considered and mitigated by the guide-
lines themselves, we know more people from ethnic
minority backgrounds die for no other reason than a
refusal to include evidence from the social sciences
during development. In clinical guidance, this is due to
a continued blind eye being turned to the social deter-
minants of health and illness and the inherent health
inequalities present in the United Kingdom. In ethical
guidance, this is due to the continued reliance on older
principles, developed without empirical evidence, often
by philosophers who could never have conceived of our
modern medical era and all the health inequalities
contained within that era. Currently endorsed by a ma-
jority of faculties and colleges from the Academy of
Medical Royal Colleges and the Royal College of Nurs-
ing, the Royal College of Physicians guidance shows
how taking account of the social sciences in developing
ethics guidance develops fair and equitable guidance
that advocates against unnecessary and discriminatory
deaths during a pandemic.
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